Results 191 to 200 of about 934,569 (347)

Retrospective evaluation of the frequency of odontogenic cysts associated with impacted teeth. [PDF]

BMC Oral Health
Koşar ÇY, Dağ B.
europepmc   +1 more source

Efficacy of digital volume tomography in the preoperative assessment of position of inferior alveolar canal with impacted mandibular third molars in a subset of Indian population

, 2018
Biyas Bhowmik, Venkatesh G. Naikmasur, Kruthika S. Guttal   +2 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Cone-beam CT evaluation of orthodontic treatment outcomes for multiple impacted maxillary anterior teeth. [PDF]

BMC Oral Health
Chen L, Mo S.
europepmc   +1 more source

Surgical Management of Impacted Mandibular Second Premolar: A Short Case Report

, 2019
Ashvini Kishor Vadane
openalex   +1 more source

High Impact [PDF]

British Journal of General Practice, 2019
openaire   +2 more sources

Impacted molars [PDF]

American Journal of Orthodontics and Dentofacial Orthopedics, 2020
openaire   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Assessment of marginal bone loss, distal caries, and external root resorption in second molars adjacent to impacted third molars: a retrospective CBCT and panoramic study. [PDF]

BMC Oral Health
Abat VH, Keser G, Yülek H, Gencoglu N, Namdar Pekiner F.   +4 more
europepmc   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source